4-aminophenylphosphate has been researched along with isoleucyl-lysyl-valyl-alanyl-valine in 1 studies
| Studies (4-aminophenylphosphate) | Trials (4-aminophenylphosphate) | Recent Studies (post-2010) (4-aminophenylphosphate) | Studies (isoleucyl-lysyl-valyl-alanyl-valine) | Trials (isoleucyl-lysyl-valyl-alanyl-valine) | Recent Studies (post-2010) (isoleucyl-lysyl-valyl-alanyl-valine) |
|---|---|---|---|---|---|
| 77 | 0 | 19 | 64 | 0 | 40 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, H; Jiang, T; Li, S; Liu, K; Qiu, T; Xu, B | 1 |
1 other study(ies) available for 4-aminophenylphosphate and isoleucyl-lysyl-valyl-alanyl-valine
| Article | Year |
|---|---|
IKVAV peptide-containing hydrogel decreases fibrous scar after spinal cord injury by inhibiting fibroblast migration and activation.
Topics: Animals; Cicatrix; Humans; Hydrogels; Mice; Peptides; Rats; Spinal Cord; Spinal Cord Injuries; Transforming Growth Factor beta1 | 2023 |